These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24075979)

  • 1. An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approach.
    Petzoldt C; Bley O; Byard SJ; Andert D; Baumgartner B; Nagel N; Tappertzhofen C; Feth MP
    Eur J Pharm Biopharm; 2014 Apr; 86(3):337-50. PubMed ID: 24075979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing mechanical activation-induced amorphisation of salbutamol sulphate by co-processing with selected carboxylic acids.
    Curtin V; Amharar Y; Gallagher KH; Corcoran S; Tajber L; Corrigan OI; Healy AM
    Int J Pharm; 2013 Nov; 456(2):508-16. PubMed ID: 23994365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
    Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
    Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
    Mohammad MA; Grimsey IM; Forbes RT
    J Pharm Biomed Anal; 2015 Oct; 114():176-83. PubMed ID: 26068908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
    Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
    Kogermann K; Veski P; Rantanen J; Naelapää K
    Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
    Skrdla PJ; Zhang D
    J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential scanning calorimetry predicts the critical quality attributes of amorphous glibenclamide.
    Mah PT; Laaksonen T; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Sci; 2015 Dec; 80():74-81. PubMed ID: 26296864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
    Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
    Liu J; Nagapudi K; Kiang YH; Martinez E; Jona J
    Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of X-ray powder diffraction and solid-state nuclear magnetic resonance in estimating crystalline fraction of tacrolimus in sustained-release amorphous solid dispersion and development of discriminating dissolution method.
    Rahman Z; Bykadi S; Siddiqui A; Khan MA
    J Pharm Sci; 2015 May; 104(5):1777-86. PubMed ID: 25753829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
    Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of low amounts of amorphous content in hydrophobic active pharmaceutical ingredients with dynamic organic vapor sorption.
    Müller T; Schiewe J; Smal R; Weiler C; Wolkenhauer M; Steckel H
    Eur J Pharm Biopharm; 2015 May; 92():102-11. PubMed ID: 25779351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
    Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of amorphous content in the pharmaceutical process environment.
    Savolainen M; Jouppila K; Pajamo O; Christiansen L; Strachan C; Karjalainen M; Rantanen J
    J Pharm Pharmacol; 2007 Feb; 59(2):161-70. PubMed ID: 17270070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets.
    Xie Y; Tao W; Morrison H; Chiu R; Jona J; Fang J; Cauchon N
    Int J Pharm; 2008 Oct; 362(1-2):29-36. PubMed ID: 18588963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dispersive Raman Spectroscopy for Quantifying Amorphous Drug Content in Intact Tablets.
    Wabuyele BW; Sotthivirat S; Zhou GX; Ash J; Dhareshwar SS
    J Pharm Sci; 2017 Feb; 106(2):579-588. PubMed ID: 27938895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.